Skip to main content

Recombinant Mouse VLDLR (Cys297) Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 6685-VL

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
6685-VL-050

Key Product Details

Source

NS0

Accession #

Conjugate

Unconjugated

Applications

Bioactivity

Product Specifications

Source

Mouse myeloma cell line, NS0-derived mouse VLDLR protein
Met1-Ala798, with a C-terminal 10-His tag

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Thr25

Predicted Molecular Mass

86.5 kDa

SDS-PAGE

110-135 kDa, reducing conditions

Activity

Measured by its binding ability in a functional ELISA.
When Recombinant Human Apolipoprotein E3 (Catalog # 4144-AE) is immobilized at 1 μg/mL (100 μL/well), the concentration of Recombinant Mouse VLDL R that produces 50% of the optimal binding response is found to be approximately 0.075‑0.375 μg/mL.

This protein has also been shown to bind to Recombinant Mouse LRPAP (Catalog # 4480-LR) and Recombinant Mouse Reelin (Catalog # 3820-MR).

Formulation, Preparation and Storage

6685-VL
Formulation Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Reconstitution
Reconstitute at 100 μg/mL in PBS.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: VLDLR

VLDL R is a 130 kDa type I transmembrane protein in the LDL receptor family that plays a significant role in lipid metabolism and in nervous system development and function (1, 2). Mouse VLDL R has a 774 aa extracellular domain (ECD) (aa 25‑798) and a 54 aa cytoplasmic domain. The ECD contains eight LDLR class A repeats, three EGF‑like domains, six LDLR class B repeats, and a juxtamembrane region that is rich in O‑linked glycosylation (3, 4, 5). The cytoplasmic domain contains one NPXY internalization motif. Mouse VLDL R has at least one 105 kDa alternative splice form. This variant (termed type II VLDL R) shows an Arg substitution for aa 751‑779, and has been associated with endothelial cells (5, 6). The VLDL R expressed here corresponds to a polymorphic form that shows a Cys at position 297 of the precursor. This generates a disulfide bond in the 7th LDL class A domain that is not present when position 297 is occupied by Ser (SwissProt # P98156). The 7th domain is suggested to be a critical determinant of apoE binding to VLDL R (7). VLDL R is predominantly expressed in striated muscle, adipose tissue, brain, and endothelial cells lining capillaries and small arterioles (3, 4, 8, 9). VLDL R participates in the tissue uptake of fatty acids from plasma by mediating the internalization of ApoE‑containing lipoparticles (i.e. VLDL, beta‑VLDL, and chylomicron remnants) (8, 10). VLDL R binds and internalizes lipoprotein lipase (LPL) and mediates its transport from the basolateral to the lumenal face of endothelial cells (9, 11). VLDL R knockout mice are characterized by reduced LPL activity, reduced serum triglyceride clearance, and a resistance to developing obesity (10, 12, 13). VLDL R influences breast cancer cell motility by mediating the uptake of uPAR‑PAI1 complexes (9, 14). Lipoprotein accumulation via macrophage VLDL R is instrumental in promoting the formation of atherosclerotic plaques (15). In the nervous system, VLDL R and ApoE R2 interactions with reelin are critical for neuronal migration and positioning in the developing brain (16). VLDL R also functions in adult hippocampal synapse maturation, synaptic plasticity, and memory formation (17, 18). The ECD of mouse VLDL R shares 95% aa sequence identity with human and rat VLDL R. Within shared regions, mouse VLDL R shares 55% and 53% aa sequence identity with ApoE R2 and LDL R, respectively.

References

  1. Qiu, S. et al. (2006) Neurobiol. Learn. Mem. 85:16.
  2. May, P. et al. (2005) Cell. Mol. Life Sci. 62:2325.
  3. Gafvels, M.E. et al. (1994) Endocrinology 135:387.
  4. Oka, K. et al. (1994) Eur. J. Biochem. 224:975.
  5. Martensen, P.M. et al. (1997) Eur. J. Biochem. 248:583.
  6. GenBank Accession # NP_001154892.
  7. Ruiz, J. et al. (2005) J. Lipid Res. 46:1721.
  8. Wyne, K.L. et al. (1996) Arterioscler. Thromb. Vasc. Biol. 16:407.
  9. Argraves, K.M. et al. (1995) J. Biol. Chem. 270:26550.
  10. Goudriaan, J.R. et al. (2001) Arterioscler. Thromb. Vasc. Biol. 21:1488.
  11. Obunike, J.C. et al. (2001) J. Biol. Chem. 276:8934.
  12. Yagyu, H. et al. (2002) J. Biol. Chem. 277:10037.
  13. Goudriaan, J.R. et al. (2004) J. Lipid Res. 45:1475.
  14. Webb, D.J. et al. (1999) J. Biol. Chem. 274:7412.
  15. van Eck, M. et al. (2005) Atherosclerosis 183:230.
  16. Jossin, Y. et al. (2004) J. Neurosci. 24:514.
  17. Niu, S. et al. (2004) Neuron 41:71.
  18. Weeber, E.J. et al. (2002) J. Biol. Chem. 277:39944.

Long Name

Very Low Density Lipoprotein Receptor

Alternate Names

CHRMQ1, VLDL R, VLDLRCH

Entrez Gene IDs

7436 (Human); 22359 (Mouse)

Gene Symbol

VLDLR

UniProt

Additional VLDLR Products

Product Documents for Recombinant Mouse VLDLR (Cys297) Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Mouse VLDLR (Cys297) Protein, CF

For research use only

Loading...
Loading...
Loading...